Background illustration for clinical trials search

Paid Clinical Trials Gainesville

Discover 648 paid clinical trials in Gainesville, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma (MM)
Location: Ocala FL, Jacksonville FL, Tamarac FL, Plantation FL,
Sponsor: Shanghai Henlius Biotech

Sex: All

Age: 18+

Code: NCT07477587

Phase 1, Recruiting

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung
Location: Ocala FL, Tampa FL, St. Petersburg FL, Fort Myers FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06890598

Phase 3, Recruiting

A Study of IBI363 in Subjects with Advanced Solid Malignancies

for
Melanoma, Non-small Cell Lung Cancer, Colorectal Cancer,
Location: Ocala FL, Plantation FL, Houston TX, Dearborn MI,
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.

Sex: All

Age: 18+

Code: NCT06281678

Phase 2, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Ocala FL, Orlando FL, St. Petersburg FL, Charleston SC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase 3, Recruiting

Patient Retrospective Outcomes (PRO)

for
Chronic Pain
Location: Ocala FL, Clermont FL, Vero Beach FL, Jupiter FL,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT01550575

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Ocala FL, Daytona Beach FL, Riverview FL, Largo FL,
Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase 2, Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for
Non-Small Cell Lung Cancer
Location: Ocala FL, Jacksonville FL, Jacksonville Beach FL,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT06767514

Phase 3, Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Ocala FL, Orlando FL, St. Petersburg FL,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase 3, Recruiting

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

for
Metabolic Dysfunction-associated Steatohepatitis
Location: Ocala FL, Miami FL, Little Rock AR, St Louis MO,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07701993

Phase 3, Recruiting

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

for
Metabolic Dysfunction-associated Steatohepatitis
Location: Ocala FL, Miami FL, Morehead City NC, Little Rock AR,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07704892

Phase 3, Recruiting

A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

for
Irritable Bowel Syndrome
Location: Ocala FL, Jacksonville FL, Orlando FL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07519395

Phase 2, Recruiting

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

for
Non-alcoholic Fatty Liver Disease
Location: Ocala FL, Inverness FL, Jacksonville FL, Clermont FL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07221188

Phase 3, Recruiting

Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Location: Ocala FL, Miami FL, North Little Rock AR, Fresno CA,
Sponsor: Altimmune, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07795164

Phase 3, Recruiting

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

for
Non-alcoholic Fatty Liver Disease
Location: Ocala FL, Inverness FL, Jacksonville FL, Clermont FL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07221227

Phase 3, Recruiting

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

for
Pulmonary Disease, Chronic Obstructive
Location: Ocala FL, Brooksville FL, Ormond Beach FL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 40 - 70+

Code: NCT06961214

Phase 3, Recruiting

An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

for
Stargardt, Stargardt's Disease, Stargardt Disease, STGD1
Location: Gainesville FL, Miami FL, Atlanta GA, Durham NC,
Sponsor: Splice Bio

Sex: All

Age: 12 - 65

Code: NCT06435000

Recruiting

Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

for
Stargardt Disease, Cone Rod Dystrophy,
Location: Gainesville FL, Miami FL, Cincinnati OH, Houston TX,
Sponsor: Ascidian Therapeutics, Inc

Sex: All

Age: 12+

Code: NCT06467344

Phase 1, Phase 2, Recruiting

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

for
Geographic Atrophy, Macular Degeneration
Location: Gainesville FL, St. Petersburg FL, Beaufort SC,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 60+

Code: NCT06635148

Phase 2, Phase 3, Recruiting

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

for
Neovascular (Wet) Age-Related Macular Degeneration
Location: Gainesville FL, Tampa FL, Melbourne FL,
Sponsor: 4D Molecular Therapeutics

Sex: All

Age: 50+

Code: NCT05197270

Phase 1, Phase 2, Recruiting

KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Lake City FL, Birmingham AL, Urbana IL, New York NY,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04640532

Phase 1, Phase 2, Recruiting